Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Thoma Bravo completes acquisition of Majesco » 12:20
09/21/20
09/21
12:20
09/21/20
12:20
MJCO

Majesco

$15.98 /

-0.01 (-0.06%)

Thoma Bravo announced…

Thoma Bravo announced that it has completed the acquisition of Majesco. As previously announced on August 8, under the terms of an amended and restated definitive merger agreement, Thoma Bravo agreed to acquire all of the issued and outstanding shares of Majesco common stock for $16.00 per share in cash. In conjunction with the closing, Majesco's common stock will cease trading before the market opens on Tuesday, September 22 and the company will no longer be listed on the Nasdaq stock exchange. Majesco will operate as a privately-held company.

ShowHide Related Items >><<
MJCO Majesco
$15.98 /

-0.01 (-0.06%)

MJCO Majesco
$15.98 /

-0.01 (-0.06%)

Hot Stocks
Majesco, KPMG collaborate to accelerate insurance digitally » 16:33
09/09/20
09/09
16:33
09/09/20
16:33
MJCO

Majesco

$16.00 /

+0.01 (+0.06%)

Majesco and KPMG are…

Majesco and KPMG are working together to accelerate insurance digital transformation using Majesco Digital1st Insurance platform. Digital1st is the a cloud-native, microservices-based digital experience platform with a low code / no code configurability and an API and partner ecosystem apps. Combined with Majesco's CloudInsurer core insurance platform, provides insurers with an end-to-end capability enabling insurers to become connected with their clients, agents and brokers.

ShowHide Related Items >><<
MJCO Majesco
$16.00 /

+0.01 (+0.06%)

MJCO Majesco
$16.00 /

+0.01 (+0.06%)

Hot Stocks
Majesco enters into amended agreement to be acquired by Thoma Bravo » 15:31
08/09/20
08/09
15:31
08/09/20
15:31
MJCO

Majesco

$13.08 /

+0.045 (+0.35%)

Majesco announced that it…

Majesco announced that it has signed an amended definitive agreement to be acquired by Thoma Bravo in a transaction valuing the company at $729M. Following the closing of the transaction, Majesco will operate as a privately held company. Under the amendment, Thoma Bravo will acquire all of Majesco's outstanding shares for $16.00 per share. The price represents a premium of approximately 113% over Majesco's average closing price of $7.52 during the 30-trading day period ended July 17, 2020. The proposed merger is subject to the approval of Majesco shareholders and the approval of the shareholders of Majesco's parent company, Majesco Limited. Majesco's and Majesco Limited's Boards of Directors have unanimously approved the merger and recommend that their respective shareholders approve the merger. Majesco Limited's promoter shareholders have entered into a voting agreement to vote in favor of a transaction with Thoma Bravo and against a competing transaction, which remains in place for a 7-month period following any termination of the transaction documents. Majesco will solicit written consents from its shareholders to approve the Merger Agreement and expects to distribute the consent solicitation statement in August 2020. The increased offer from Thoma Bravo and the amendment followed Majesco's receipt of an unsolicited acquisition proposal from an unaffiliated third party. Completion of the merger is not subject to a financing condition but is subject to the accuracy of the representations and warranties, performance of the covenants and other agreements included in the Merger Agreement and customary closing conditions for a transaction of this type, including regulatory approvals in the U.S. and India. Assuming satisfaction of those conditions, the company expects the merger to close by the end of 2020.

ShowHide Related Items >><<
MJCO Majesco
$13.08 /

+0.045 (+0.35%)

MJCO Majesco
$13.08 /

+0.045 (+0.35%)

Over a quarter ago
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:30
07/20/20
07/20
16:30
07/20/20
16:30
EBAY

eBay

$58.45 /

+0.32 (+0.55%)

, ADEVF

Adevinta

$0.00 /

+ (+0.00%)

, CVX

Chevron

$85.31 /

-1.91 (-2.19%)

, NBL

Noble Energy

$10.19 /

+0.53 (+5.49%)

, MJCO

Majesco

$13.22 /

+5.35 (+67.98%)

, AZN

AstraZeneca

$58.68 /

-2.44 (-3.99%)

, BNTX

BioNTech

$88.26 /

+3.1 (+3.64%)

, PFE

Pfizer

$36.50 /

+0.26 (+0.72%)

, CZR

Caesars

$12.39 /

-0.02 (-0.16%)

, ERI

Eldorado Resorts

$38.18 /

+0.18 (+0.47%)

, SRNE

Sorrento Therapeutics

$8.35 /

+1.38 (+19.80%)

, OPK

Opko Health

$4.94 /

+0.35 (+7.63%)

, NKLA

Nikola

$38.44 /

-10.31 (-21.15%)

, PETS

PetMed Express

$33.35 /

-7.1 (-17.55%)

The major averages were…

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$8.35 /

+1.38 (+19.80%)

PFE Pfizer
$36.50 /

+0.26 (+0.72%)

PETS PetMed Express
$33.35 /

-7.1 (-17.55%)

OPK Opko Health
$4.94 /

+0.35 (+7.63%)

NKLA Nikola
$38.44 /

-10.31 (-21.15%)

NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

MJCO Majesco
$13.22 /

+5.35 (+67.98%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

CVX Chevron
$85.31 /

-1.91 (-2.19%)

BNTX BioNTech
$88.26 /

+3.1 (+3.64%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

07/20/20 Goldman Sachs
eBay price target raised to $56 from $49 at Goldman Sachs
07/15/20 Baird
eBay data holding steady above pre-COVID volumes, says Baird
07/14/20 Stifel
eBay price target raised to $66 from $52 at Stifel
07/13/20 Barclays
eBay price target raised to $77 from $52 at Barclays
ADEVF Adevinta
$0.00 /

+ (+0.00%)

07/17/20 JPMorgan
Adevinta price target raised to NOK 129 from NOK 113 at JPMorgan
06/02/20 Deutsche Bank
Adevinta price target raised to NOK 110 from NOK 100 at Deutsche Bank
04/22/20 JPMorgan
Adevinta price target raised to NOK 101 from NOK 97 at JPMorgan
04/03/20 Kepler Cheuvreux
Adevinta upgraded to Hold from Reduce at Kepler Cheuvreux
CVX Chevron
$85.31 /

-1.91 (-2.19%)

07/20/20 BMO Capital
Noble Energy downgraded to Market Perform from Outperform at BMO Capital
07/20/20 Stifel
Stifel says Noble deal 'neutral for sector at best' if no competing bid arises
06/10/20
Fly Intel: Top five analyst downgrades
06/10/20
Chevron cut to Underperform at RBC Capital on valuation
NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

07/20/20 RBC Capital
Noble Energy downgraded to Sector Perform from Outperform at RBC Capital
07/20/20 MKM Partners
Noble Energy downgraded to Neutral from Buy at MKM Partners
MJCO Majesco
$13.22 /

+5.35 (+67.98%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

07/20/20 Jefferies
AstraZeneca slide 'overdone' after 'encouraging' vaccine data, says Jefferies
06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
BNTX BioNTech
$88.26 /

+3.1 (+3.64%)

07/21/20 Canaccord
BioNTech price target raised to $97 from $75 at Canaccord
07/20/20 BofA
BioNTech upgraded to Buy from Neutral at BofA
07/13/20 Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
PFE Pfizer
$36.50 /

+0.26 (+0.72%)

07/14/20 Mizuho
IPR not likely to impact uniQure's ability to commercialize AMT-061, says Mizuho
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
CZR Caesars
$12.39 /

-0.02 (-0.16%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

06/12/20 Truist
SunTrust raises price target on select Gaming names amid positive room-rate data
SRNE Sorrento Therapeutics
$8.35 /

+1.38 (+19.80%)

07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
OPK Opko Health
$4.94 /

+0.35 (+7.63%)

06/09/20 Piper Sandler
Opko Health price target raised to $4 from $3 at Piper Sandler
06/08/20 Piper Sandler
Opko Health, Pfizer data show IGF-1 normal at ENDO, says Piper Sandler
06/01/20 Piper Sandler
Piper keeps Overweight rating on Opko Health as FDA clears COVID-19 trial start
NKLA Nikola
$38.44 /

-10.31 (-21.15%)

07/20/20 Deutsche Bank
Nikola filing may bring 'large technical selling pressure,' says Deutsche Bank
07/16/20
Fly Intel: Top five analyst initiations
07/16/20 Deutsche Bank
Nikola initiated with a Hold at Deutsche Bank
07/08/20
Fly Intel: Top five analyst upgrades
PETS PetMed Express
$33.35 /

-7.1 (-17.55%)

04/09/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
PFE Pfizer
$36.50 /

+0.26 (+0.72%)

PETS PetMed Express
$33.35 /

-7.1 (-17.55%)

OPK Opko Health
$4.94 /

+0.35 (+7.63%)

NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

CVX Chevron
$85.31 /

-1.91 (-2.19%)

BNTX BioNTech
$88.26 /

+3.1 (+3.64%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

  • 17
    Jun
  • 06
    Feb
  • 25
    Oct
  • 10
    Oct
SRNE Sorrento Therapeutics
$8.35 /

+1.38 (+19.80%)

PFE Pfizer
$36.50 /

+0.26 (+0.72%)

OPK Opko Health
$4.94 /

+0.35 (+7.63%)

NKLA Nikola
$38.44 /

-10.31 (-21.15%)

NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

CVX Chevron
$85.31 /

-1.91 (-2.19%)

BNTX BioNTech
$88.26 /

+3.1 (+3.64%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

SRNE Sorrento Therapeutics
$8.35 /

+1.38 (+19.80%)

OPK Opko Health
$4.94 /

+0.35 (+7.63%)

NKLA Nikola
$38.44 /

-10.31 (-21.15%)

NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

CVX Chevron
$85.31 /

-1.91 (-2.19%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

SRNE Sorrento Therapeutics
$8.35 /

+1.38 (+19.80%)

PFE Pfizer
$36.50 /

+0.26 (+0.72%)

OPK Opko Health
$4.94 /

+0.35 (+7.63%)

NKLA Nikola
$38.44 /

-10.31 (-21.15%)

NBL Noble Energy
$10.19 /

+0.53 (+5.49%)

ERI Eldorado Resorts
$38.18 /

+0.18 (+0.47%)

EBAY eBay
$58.45 /

+0.32 (+0.55%)

CZR Caesars
$12.39 /

-0.02 (-0.16%)

CVX Chevron
$85.31 /

-1.91 (-2.19%)

BNTX BioNTech
$88.26 /

+3.1 (+3.64%)

AZN AstraZeneca
$58.68 /

-2.44 (-3.99%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:46
07/20/20
07/20
12:46
07/20/20
12:46
CVX

Chevron

$86.08 /

-1.14 (-1.31%)

, NBL

Noble Energy

$10.15 /

+0.49 (+5.07%)

, EBAY

eBay

$58.39 /

+0.255 (+0.44%)

, AZN

AstraZeneca

$58.77 /

-2.35 (-3.84%)

, PFE

Pfizer

$36.45 /

+0.21 (+0.58%)

, BNTX

BioNTech

$86.52 /

+1.36 (+1.60%)

, MJCO

Majesco

$13.00 /

+5.13 (+65.18%)

, SRNE

Sorrento Therapeutics

$8.09 /

+1.12 (+16.07%)

, BTAI

BioXcel Therapeutics

$60.07 /

+7.01 (+13.21%)

, NKLA

Nikola

$38.94 /

-9.81 (-20.12%)

, PETS

PetMed Express

$34.04 /

-6.41 (-15.85%)

The major averages are…

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$8.09 /

+1.12 (+16.07%)

PFE Pfizer
$36.45 /

+0.21 (+0.58%)

PETS PetMed Express
$34.04 /

-6.41 (-15.85%)

NKLA Nikola
$38.94 /

-9.81 (-20.12%)

NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

MJCO Majesco
$13.00 /

+5.13 (+65.18%)

EBAY eBay
$58.39 /

+0.255 (+0.44%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

BTAI BioXcel Therapeutics
$60.07 /

+7.01 (+13.21%)

BNTX BioNTech
$86.52 /

+1.36 (+1.60%)

AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

07/20/20 Stifel
Stifel says Noble deal 'neutral for sector at best' if no competing bid arises
06/10/20
Fly Intel: Top five analyst downgrades
06/10/20
Chevron cut to Underperform at RBC Capital on valuation
06/10/20 RBC Capital
Chevron downgraded to Underperform from Sector Perform at RBC Capital
NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

07/20/20 MKM Partners
Noble Energy downgraded to Neutral from Buy at MKM Partners
06/19/20 Mizuho
Noble Energy price target raised to $14 from $12 at Mizuho
05/21/20 Mizuho
Noble Energy price target raised to $12 from $10 at Mizuho
EBAY eBay
$58.39 /

+0.255 (+0.44%)

07/20/20 Goldman Sachs
eBay price target raised to $56 from $49 at Goldman Sachs
07/15/20 Baird
eBay data holding steady above pre-COVID volumes, says Baird
07/14/20 Stifel
eBay price target raised to $66 from $52 at Stifel
07/13/20 Barclays
eBay price target raised to $77 from $52 at Barclays
AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
PFE Pfizer
$36.45 /

+0.21 (+0.58%)

07/14/20 Mizuho
IPR not likely to impact uniQure's ability to commercialize AMT-061, says Mizuho
07/13/20 Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
BNTX BioNTech
$86.52 /

+1.36 (+1.60%)

07/02/20 B. Riley Securities
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
MJCO Majesco
$13.00 /

+5.13 (+65.18%)

SRNE Sorrento Therapeutics
$8.09 /

+1.12 (+16.07%)

07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
BTAI BioXcel Therapeutics
$60.07 /

+7.01 (+13.21%)

07/20/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $200 from $120 at H.C. Wainwright
07/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $120 from $95 at H.C. Wainwright
06/05/20 Guggenheim
Guggenheim starts BioXcel Therapeutics at Buy on optimistic view of lead asset
06/04/20 Guggenheim
BioXcel Therapeutics initiated with a Buy at Guggenheim
NKLA Nikola
$38.94 /

-9.81 (-20.12%)

07/20/20 Deutsche Bank
Nikola filing may bring 'large technical selling pressure,' says Deutsche Bank
07/16/20
Fly Intel: Top five analyst initiations
07/16/20 Deutsche Bank
Nikola initiated with a Hold at Deutsche Bank
07/08/20
Fly Intel: Top five analyst upgrades
PETS PetMed Express
$34.04 /

-6.41 (-15.85%)

04/09/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
PFE Pfizer
$36.45 /

+0.21 (+0.58%)

PETS PetMed Express
$34.04 /

-6.41 (-15.85%)

NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

EBAY eBay
$58.39 /

+0.255 (+0.44%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

BTAI BioXcel Therapeutics
$60.07 /

+7.01 (+13.21%)

BNTX BioNTech
$86.52 /

+1.36 (+1.60%)

AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

  • 20
    Feb
  • 06
    Feb
  • 26
    Sep
  • 10
    Oct
SRNE Sorrento Therapeutics
$8.09 /

+1.12 (+16.07%)

PFE Pfizer
$36.45 /

+0.21 (+0.58%)

NKLA Nikola
$38.94 /

-9.81 (-20.12%)

NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

EBAY eBay
$58.39 /

+0.255 (+0.44%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

BNTX BioNTech
$86.52 /

+1.36 (+1.60%)

AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

SRNE Sorrento Therapeutics
$8.09 /

+1.12 (+16.07%)

PFE Pfizer
$36.45 /

+0.21 (+0.58%)

NKLA Nikola
$38.94 /

-9.81 (-20.12%)

NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

EBAY eBay
$58.39 /

+0.255 (+0.44%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

BTAI BioXcel Therapeutics
$60.07 /

+7.01 (+13.21%)

AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

SRNE Sorrento Therapeutics
$8.09 /

+1.12 (+16.07%)

PFE Pfizer
$36.45 /

+0.21 (+0.58%)

NKLA Nikola
$38.94 /

-9.81 (-20.12%)

NBL Noble Energy
$10.15 /

+0.49 (+5.07%)

EBAY eBay
$58.39 /

+0.255 (+0.44%)

CVX Chevron
$86.08 /

-1.14 (-1.31%)

BTAI BioXcel Therapeutics
$60.07 /

+7.01 (+13.21%)

BNTX BioNTech
$86.52 /

+1.36 (+1.60%)

AZN AstraZeneca
$58.77 /

-2.35 (-3.84%)

Hot Stocks
Majesco to be acquired by Thoma Bravo for $13.10 per share in cash » 09:15
07/20/20
07/20
09:15
07/20/20
09:15
MJCO

Majesco

$7.87 /

+ (+0.00%)

Majesco announced that it…

Majesco announced that it has signed a definitive agreement to be acquired by Thoma Bravo, L.P., a private equity firm focused on the software and technology-enabled services sectors, in a transaction valuing the company at $594M. Majesco said in a release, "Following the closing of the transaction, Majesco will operate as a privately held company. Under the terms of the agreement, all Majesco shareholders of record will receive $13.10 in cash for each share of Majesco common stock upon closing of the transaction. The price represents a premium of approximately 74% over Majesco's average closing price during the 30-trading day period ended July 17. The proposed merger is subject to the approval of Majesco shareholders and the approval of the shareholders of Majesco's parent company, Majesco Limited. Majesco's Board of Directors has unanimously approved the merger and recommends that shareholders approve the merger and Majesco Limited's Board of Directors has unanimously approved the divestment of Majesco and recommended to its shareholder to approve the transaction. Majesco will solicit written consents from its shareholders to approve the Merger Agreement and expects to distribute the written consents in August. Completion of the merger is not subject to a financing condition but is subject to the accuracy of the representations and warranties, performance of the covenants and other agreements included in the Merger Agreement and customary closing conditions for a transaction of this type, including regulatory approvals in the US and India. Assuming satisfaction of those conditions, the Company expects the merger to close on or before the end of 2020. Upon completion of the transaction, Majesco expects to continue to operate under the leadership of CEO Adam Elster and the existing Majesco Leadership Team."

ShowHide Related Items >><<
MJCO Majesco
$7.87 /

+ (+0.00%)

Hot Stocks
Majesco's Digital1st insurance platform chosen by Millers Mutual » 17:01
05/26/20
05/26
17:01
05/26/20
17:01
MJCO

Majesco

$6.80 /

+0.2 (+3.03%)

Majesco announced their…

Majesco announced their partnership with Millers Mutual to use cloud-native Digital1st Insurance platform to develop their next generation engagement and experience for customers, agents and employees.

ShowHide Related Items >><<
MJCO Majesco
$6.80 /

+0.2 (+3.03%)

Hot Stocks
Majesco trading resumes  09:40
05/15/20
05/15
09:40
05/15/20
09:40
MJCO

Majesco

$5.11 /

+ (+0.00%)

 
ShowHide Related Items >><<
MJCO Majesco
$5.11 /

+ (+0.00%)

Hot Stocks
Majesco trading halted, volatility trading pause  09:35
05/15/20
05/15
09:35
05/15/20
09:35
MJCO

Majesco

$5.11 /

-0.14 (-2.67%)

 
ShowHide Related Items >><<
MJCO Majesco
$5.11 /

-0.14 (-2.67%)

Hot Stocks
Majesco trading resumes  10:54
03/16/20
03/16
10:54
03/16/20
10:54
MJCO

Majesco

$5.50 /

+ (+0.00%)

 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.